Cerity Partners LLC Acadia Pharmaceuticals Inc Transaction History

Cerity Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $231,127 - $400,933	12,992 New	12,992 $240,000
Q3 2021 Oct 25, 2021	SELL	$15.78 - $24.77 $247,177 - $387,997	-15,664 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$19.4 - $27.42 $97,000 - $137,100	-5,000 Reduced 24.2%	15,664 $382,000
Q1 2021 Aug 11, 2021	BUY	$25.02 - $54.99 $517,013 - $1.14 Million	20,664 New	20,664 $533,000
Q1 2021 May 12, 2021	SELL	$25.02 - $54.99 $141,713 - $311,463	-5,664 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$41.04 - $56.79 $232,450 - $321,658	5,664 New	5,664 $303,000

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.